Proteomics Market, By Product (Reagents, Instruments, and Services), By Application (Clinical Diagnostics, and Drug Discovery), By Technology and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The proteomics market is estimated to represent a global market of USD 13.4 billion by 2017 with growth rate of 10.2%.
Market Dynamics
Proteomics is defined as the large-scale study of protein molecules particularly their structures, composition, interactions, and functions. It represents the complete set of the protein encoded by the genome. This study helps in understanding the structure and function of different proteins and alteration in protein expressions during stress condition or different stages of the life cycle. Proteomics technique provides a clear understanding of the organism rather than genomics. Further, as protein molecules are the most favorable targets for therapeutics, detailed analysis of proteins offers great opportunities for the drug development and biological processes. Thereby, after genomics, this biological discipline is usually considered as the advanced step during the study of biological systems. Based on the protein response, this technique is classified into structural, expression, and functional proteomics. Factors such as favorable government initiatives for proteomic research and growing importance among public funding institutions bode well for the worldwide proteomics market.
However, it is noted that this biological discipline inherently demands huge capital investments and historically, the investment has yielded poor revenues. Thus, despite these growth opportunities, low return on investment can dissuade companies in adopting proteomics technologies for drug developments. In addition to this, strict regulatory approvals and the high cost of instruments act as a potential barrier for this industry growth.
Product Takeaway
Product segment is categorized as Reagents, Instruments, and Services. Reagent accounted for over 30% industry share, comprise of electrophoresis kits, sample kits, purification kits among others. Application segment is bifurcated into Clinical Diagnostics, Drug Discovery, and others. This technology is widely used in clinical diagnostics and therapeutics development, mainly applied in tumor biology, and biomedicine.
Technology Takeaway
Depending upon technology, the market is bifurcated as Spectroscopy, X-Ray Crystallography, Microarray Instruments, Electrophoresis, Protein Fractionation Systems, and Surface Plasma Resonance (SPR) Systems. Of these, electrophoresis and microarray Instruments accounted for the significant revenue share. 2DE (Two-dimensional electrophoresis) is considered to be the most cost-effective protein profiling technologies.
Regional Takeaway
Regionally, the market is classified as North America, Europe, Asia Pacific and Rest of the World. With the highest share, North America surfaced up as ruling party for proteomics market, followed by Europe. Increasing interest in integrated technologies is supporting the rapid expansion of protein biochip and bio-informatics technologies, establishing a healthy platform for market growth in developed regions. Emerging economies of the Asia Pacific and Latin America set to manifest a higher CAGR, supported by a rising focus on biotech research coupled with the growing outsourcing of proteomics research.
Key Vendor Takeaway
Companies namely Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Roche Diagnostics, Sigma – Aldrich and Illumina, Inc. are operating in this market. Companies are engaged in introducing new products to capture a large customer base. For instance, in June 2015, Agilent Technologies introduced an updated gene expression microarray for studying the expression of miRNA, mRNA and IncRNA in human, mouse, and rate model.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCT
- Reagents
- Instruments
- Services
MARKET, BY APPLICATION
- Clinical Diagnostics
- Drug Discovery
- Others
MARKET, BY TECHNOLOGY
- Spectroscopy
- X-Ray Crystallography
- Microarray Instruments
- Electrophoresis
- Protein Fractionation Systems
- Surface Plasma Resonance (SPR) Systems
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. PROTEOMICS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. PROTEOMICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. PROTEOMICS INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. PROTEOMICS MARKET LANDSCAPE
5.1. Market Share Analysis
6. PROTEOMICS MARKET – BY PRODUCT
6.1. Overview
6.2. Reagents
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Instruments
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. Services
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. PROTEOMICS MARKET – BY APPLICATION
7.1. Overview
7.2. Clinical Diagnostics
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Drug Discovery
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4. Others
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. PROTEOMICS MARKET – BY TECHNOLOGY
8.1. Overview
8.2. Spectroscopy
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. X-Ray Crystallography
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. Microarray Instruments
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5. Electrophoresis
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.6. Protein Fractionation Systems
8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.7. Surface Plasma Resonance (SPR) Systems
8.7.1. Overview
8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. PROTEOMICS MARKET– BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.3. U.S.
9.2.3.1. Overview
9.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.2.4. Canada
9.2.4.1. Overview
9.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3. Europe
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.3. France
9.3.3.1. Overview
9.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.4. Germany
9.3.4.1. Overview
9.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.3.5. Rest of Europe
9.3.5.1. Overview
9.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.3. China
9.4.3.1. Overview
9.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.4. India
9.4.4.1. Overview
9.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.4.5. Rest of APAC
9.4.5.1. Overview
9.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5. Rest of the World
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.3. Latin America
9.5.3.1. Overview
9.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9.5.4. Middle East and Africa
9.5.4.1. Overview
9.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
10. KEY VENDOR ANALYSIS
10.1. Agilent Technologies
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. Bio-Rad Laboratories
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. GE Healthcare
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. Roche Diagnostics
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Sigma – Aldrich
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
10.6. Illumina, Inc.
10.6.1. Company Overview
10.6.2. SWOT Analysis
10.6.3. Key Developments
*Client can request additional company profiling as per specific requirements
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. Abbreviations
12.3. Disclaimer
12.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Proteomics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Proteomics Market, by Product, 2014 – 2025 (USD Billion)
Table 11 Proteomics Market, by Application, 2014 – 2025 (USD Billion)
Table 12 Proteomics Market, by Technology, 2014 – 2025 (USD Billion)
Table 13 Proteomics Market, by Geography, 2014 – 2025 (USD Billion)
Table 14 North America Proteomics Market, 2014 – 2025 (USD Billion)
Table 15 U.S. Proteomics Market, 2014 – 2025 (USD Billion)
Table 16 Canada Proteomics Market, 2014 – 2025 (USD Billion)
Table 17 Europe Proteomics Market, 2014 – 2025 (USD Billion)
Table 18 France Proteomics Market, 2014 – 2025 (USD Billion)
Table 19 Germany Proteomics Market, 2014 – 2025 (USD Billion)
Table 20 Asia Pacific Proteomics Market, 2014 – 2025 (USD Billion)
Table 21 China Proteomics Market, 2014 – 2025 (USD Billion)
Table 22 India Proteomics Market, 2014 – 2025 (USD Billion)
Table 23 Latin America Proteomics Market, 2014 – 2025 (USD Billion)
Table 24 MEA Proteomics Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Proteomics Market, by Product, 2014 – 2025 (USD Billion)
Figure 6 Proteomics Market, by Application, 2014 – 2025 (USD Billion)
Figure 7 Proteomics Market, by Technology, 2014 – 2025 (USD Billion)
Figure 8 Proteomics Market, by Geography, 2014 – 2025 (USD Billion)
